Aethlon Medical (AEMD) Depreciation & Amortization (CF) (2010 - 2026)

Aethlon Medical's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $79547.0 for Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 5.15% year-over-year to $79547.0; the trailing twelve-month figure through Mar 2026 stood at $323653.0 (down 4.68% YoY), and the FY2026 full-year result was $323653.0, down 4.68% from the prior year.
• Depreciation & Amortization (CF) was $79547.0 for Q1 2026 at Aethlon Medical, down from $81603.0 in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for AEMD reached as high as $91473.0 in Q4 2023 and fell as low as $25322.0 in Q1 2022.
• Median Depreciation & Amortization (CF) over the past 5 years was $82637.0 (2025), compared with a mean of $75793.1.
• On a YoY basis, Depreciation & Amortization (CF) climbed as much as 342.06% in 2022 and fell as far as 23.83% in 2022.
• Over 5 years, Depreciation & Amortization (CF) stood at $78126.0 in 2022, then grew by 17.08% to $91473.0 in 2023, then decreased by 8.38% to $83808.0 in 2024, then slipped by 2.63% to $81603.0 in 2025, then fell by 2.52% to $79547.0 in 2026.
• Business Quant data shows AEMD's Depreciation & Amortization (CF) at $79547.0 in Q1 2026, $81603.0 in Q4 2025, and $79866.0 in Q3 2025.